Results
|
|
1.
|
Outcomes in atrial fibrillation patients with and without left ventricular hypertrophy when treated with a lenient rate-control or rhythm-control strategy. MedStar authors:
Year: 2014
Citation: - American Journal of Cardiology. 113(7):1159-65, 2014 Apr 1.
Institution: - MedStar Washington Hospital Center
Department: - Medicine/General Internal Medicine
Medline publication type:
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
All authors: - Arora S, Badheka AO, Bhalara V, Chothani A, Coffey JO, Deshmukh A, Grover PM, Halperin JL, Mehta K, Mitrani RD, Panaich SS, Patel N, Patel NJ, Rathod A, Savani GT, Shah N, Singh V, Viles-Gonzalez JF
|
|
|
2.
|
Variation in Antithrombotic Therapy and Clinical Outcomes in Patients With Preexisting Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement: Insights From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. MedStar authors:
Year: 2021
Citation: - Circulation: Cardiovascular Interventions. 14(4):e009963, 2021 04.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Cohen DJ, Dai D, Gupta A, Harrison JK, Holmes DR, Kirtane AJ, Li Z, Mack MJ, Peterson ED, Piccini J, Rumsfeld JS, Sherwood MW, Thourani VH, Vemulapalli S, Vora AN
|
|
|
3.
|
Albumin and bleed risk in rivaroxaban treated patients. MedStar authors:
Year: 2020
Citation: - Journal of Thrombosis & Thrombolysis. 50(4):1004-1011, 2020 Nov.
Institution: - MedStar Union Memorial Hospital
Medline publication type:
All authors: - Chen L, Cheruvil C, Hassan A, Holsen MR, Rossi M, Wilcox N, Wojakowski E
|
|
|
4.
|
|
